J. Birktoft

Structure and Biology of Tissue Factor Pathway Inhibitor

J. Birktoft, S. Bajaj, S. P. Bajaj, 2001, Thrombosis and Haemostasis.

Revised cDNA sequence of rabbit tissue factor pathway inhibitor.

S. Bajaj, A. Belaaouaj, M. Kuppuswamy, 1993, Thrombosis research.

Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.

S. Bajaj, J. Gorka, J. Birktoft, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX.

H. Brackmann, K. Olek, K. Smith, 1992, Blood.

Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin.

J. Sheehan, J. Sadler, S. Lentz, 1991, Proceedings of the National Academy of Sciences of the United States of America.

First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.

K. Smith, S. Bajaj, J. Birktoft, 1994, Proceedings of the National Academy of Sciences of the United States of America.

growth factor-like domain Factor IXHollywood: substitution of Pro55 by Ala in the first epidermal

S. Spitzer, S. Bajaj, C. Kasper, 2011 .

Factor IXHollywood: substitution of Pro55 by Ala in the first epidermal growth factor-like domain.

S. Spitzer, S. Bajaj, C. Kasper, 1990, Blood.

Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX.

J. Birktoft, H. Brackmann, K. Olek, 1992, Blood.

protease domain of factor IX Hemophilia B caused by five different nondeletion mutations in the

H. Brackmann, K. Olek, S. Bajaj, 2011 .